TSE:BUX Stock Latest News
Company AnnouncementsBioMark to Spotlight Metabolomics Platform at Quebec Life Sciences Conferences1M ago
Company AnnouncementsBioMark Wins Global Scientific Backing for AI-Driven Lung Cancer Blood Test2M ago
Company AnnouncementsBioMark to Showcase Home-Based Lung Cancer Blood Test at Canadian Thoracic Forum6M ago
Company AnnouncementsBioMark Wins Peer-Reviewed Validation for AI-Driven Lung Cancer Detection Model9M ago
Company AnnouncementsBioMark Wins Peer-Reviewed Validation for AI-Driven Lung Cancer Detection Model9M ago
Company AnnouncementsBioMark Leverages Landmark Lung Cancer Studies and New Funding to Drive 2026 Expansion10M agoCompany AnnouncementsBioMark Adds AI-Focused Investor James Lavender to Board to Drive U.S. Expansion10M ago
Company AnnouncementsBioMark Launches ISO 15189 Accreditation Drive to Accelerate Global Commercialization10M ago
Company AnnouncementsBioMark Diagnostics Wins Innovation Award for Lung Cancer Screening Project11M ago
Company AnnouncementsBioMark Supports National Plan to Slash Lung Cancer Mortality11M ago
Company AnnouncementsBioMark Joins Landmark German Lung Cancer Screening Trial1y ago
Company AnnouncementsBioMark Secures Patents in China and Japan for Lung Cancer Detection1y ago
Company AnnouncementsBioMark Diagnostics Expands into North Africa with Strategic Partnership1y agoCompany AnnouncementsBioMark Diagnostics Expands Laboratory Services to Boost Lung Cancer Assay Commercialization1y ago
Company AnnouncementsBioMark Diagnostics Announces 2025 Achievements and Strategic Milestones for 2025-20261y ago
Company AnnouncementsBioMark Diagnostics Unveils AI Breakthrough in Early Lung Cancer Detection1y ago
Company AnnouncementsBioMark Diagnostics Validates High Accuracy of Early-Stage Lung Cancer Test1y ago
Company AnnouncementsBioMark Diagnostics Uplists to OTCQB, Boosting U.S. Market Presence1y ago
Company AnnouncementsBioMark Diagnostics Closes Oversubscribed Private Placement to Boost Commercialization1y ago
Company AnnouncementsBioMark Diagnostics Secures $2 Million Investment to Advance Cancer Detection Platform1y agoCompany AnnouncementsBioMark Diagnostics Reaffirms Commitment to Rare Disease Research on Rare Disease Day 20251y ago

